The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Correlation between K-RAS mutant subsets, TP53 mutation, and PD-L1 status in non-small cell lung cancer (NSCLC).
 
Nagla Fawzy Abdel Karim
Consulting or Advisory Role - Immunocore
Speakers' Bureau - AstraZeneca; Genentech; Merck; Merck; Novartis; Novartis
Research Funding - Pfizer
Patents, Royalties, Other Intellectual Property - Detection of LC3 in peripheral blood. Patent in submission. (Inst)
 
Chisom Onuoha
No Relationships to Disclose
 
Imran Ahmad
No Relationships to Disclose
 
Ihab Eldessouki
Patents, Royalties, Other Intellectual Property - Detection of LC3 in peripheral blood patient in submission) (Inst); Detection of LC3 in peripheral blood patient in submission) (Inst)
 
Patrick C. Ma
Stock and Other Ownership Interests - Cymeta Biopharmaceutical
Consulting or Advisory Role - Apollomics; AstraZeneca; Takeda
Speakers' Bureau - AstraZeneca; Bayer; Bristol-Myers Squibb; Merck; Takeda
Research Funding - Abbvie (Inst); Apollomics (Inst); AstraZeneca (Inst); Boehringer Ingelheim (Inst); Bristol-Myers Squibb (Inst); Cymeta Biopharmaceutical (Inst); EpicentRx (Inst); Loxo (Inst); MedImmune (Inst); Merck (Inst); OncoMed (Inst); Pfizer (Inst); Tesaro (Inst); Xcovery (Inst)
Travel, Accommodations, Expenses - Caris Life Sciences
 
Rebecca Feldman
Employment - Caris Life Sciences
 
Hirva Mamdani
Consulting or Advisory Role - Tempus
 
David Craig Portnoy
Employment - CNS Healthcare (I)
Research Funding - Lilly
 
Alexander I. Spira
Honoraria - AstraZeneca/MedImmune; CytomX Therapeutics; Merck
Consulting or Advisory Role - Array BioPharma (Inst)
Research Funding - Abbvie (Inst); Archer (Inst); Astellas Pharma (Inst); Astex Pharmaceuticals (Inst); AstraZeneca (Inst); Boehringer Ingelheim (Inst); Bristol-Myers Squibb (Inst); CytomX Therapeutics (Inst); Ignyta (Inst); Incyte (Inst); LAM Therapeutics; LAM Therapeutics (Inst); Loxo (Inst); Macrogenics (Inst); MedImmune (Inst); Newlink Genetics (Inst); Novartis (Inst); Roche (Inst); Takeda (Inst); Trovagene (Inst)
 
Stephen V. Liu
Consulting or Advisory Role - AstraZeneca; Bristol-Myers Squibb; Celgene; Genentech; HERON; Lilly; Pfizer; Regeneron; Taiho Pharmaceutical; Takeda
Research Funding - AstraZeneca; Bayer; Blueprint Medicines; Clovis Oncology; Corvus Pharmaceuticals; Esanex; Genentech/Roche; Lilly; Lycera; Merck; Molecular Partners; OncoMed; Pfizer; Threshold Pharmaceuticals
 
Abdul Rafeh Naqash
No Relationships to Disclose